AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback